JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Jasper Therapeutics, Inc. ("Jasper" or "the Company") (NASDAQ:JSPR) and certain of its officers. Class Definition This lawsuit seeks to recover […]

SINA Investors Have Opportunity to Lead Sina Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sina Corporation ("Sina" or "the Company") (NASDAQ:SINA) and certain of its officers. Class Definition This lawsuit seeks to recover damages

Tellihealth Appoints Chuck Washburn as Chief Revenue Officer to Accelerate Growth and Strengthen Provider Partnerships

Tellihealth, a leader in intelligent remote care solutions, today announced the appointment of Chuck Washburn as Chief Revenue Officer (CRO). In this role, Washburn will lead the company's revenue strategy, go-to-market execution, and customer experience initiatives, reporting directly to CEO Asif Ahmad. https://mma.prnewswire.com/media/2677417/Tellihealth_Logo.jpg As CRO, Washburn will oversee Tellihealth's marketing and sales teams, driving alignment

MLTX STOCK NOTICE: MoonLake Immunotherapeutics Investors with Losses may have been Affected by Fraud – Contact BFA Law before December 15 Lawsuit Deadline

MLTX STOCK NOTICE: MoonLake Immunotherapeutics Investors with Losses may have been Affected by Fraud – Contact BFA Law before December 15 Lawsuit Deadline GlobeNewswire October 22, 2025 NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ:

BAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Baxter International, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Baxter International, Inc. ("Baxter" or "the Company") (NYSE:BAX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

Ripley PR founder and CEO Heather Ripley to present at PHCC CONNECT 2025

The public relations veteran and skilled trades expert will share proactive strategies for brand-building and community connection Ripley PR, the nation's top public relations agency specializing in the home service and skilled trades industries, announces that founder and CEO Heather Ripley will speak at PHCC CONNECT 2025, the premier annual conference and expo of the

New study exposes impact of non-clinical administration on physician burnout

The study by medical billing platform,Dr.Bill, reveals that Canadian physicians are devoting nearly a full day each week to overlooked non-clinical administration. Canadian physicians cite administrative burden as one of the leading causes of stress and burnout1. While much of the conversation has focused on clinical paperwork and electronic medical records, a new study from

SIX IN 10 CONSTRUCTION WORKERS EXPERIENCE ANXIETY AND DEPRESSION; EXECUTIVES ACKNOWLEDGE THOSE WHO SEEK HELP OFTEN FACE STIGMA, DISCRIMINATION

Clayco Calls on Construction Sector to Establish Best Practices to Address Industry-Wide Mental Health Crisis Sixty-four percent of U.S. construction workers report experiencing anxiety or depression in the last 12 months, up from 54% in 2024, according to new data released today by top design-build firm Clayco.The findings are the result of Clayco's second annual

Dupixent® (dupilumab injection) approved in Canada for adults with inadequately controlled Chronic Obstructive Pulmonary Disease (COPD)

— Dupixent® is the first and only biologic approved for adults living with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by elevated blood eosinophiles – and the first new treatment option approved in over a decade — COPD is the 5th leading cause of death in Canada1,2 — COPD represents the sixth approved indication

Argentina Lithium & Energy Corp. Announces Initial Mineral Resource Estimate at the Rincon West Lithium Project

TSX Venture Exchange (TSX-V): LIT Frankfurt Stock Exchange (FSE): OAY3 OTCQX Venture Market: LILIF Argentina Lithium & Energy Corp. (TSX-V: LIT, FSE: OAY3, OTCQX: LILIF), (“Argentina Lithium” or the “Company”) is pleased to announce the results of the first Mineral Resource estimate (“MRE”) for the Rincon West lithium brine project in Salta Province, Argentina (“Rincon

Scroll to Top